Renaissance Technologies
KZIA

Renaissance Technologies’s Kazia Therapeutics KZIA Stock Holding History

Renaissance Technologies’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-449
Closed -$189K – 4300
2021
Q4 		$189K Sell
449
-51
-10% -$25.4K ﹤0.01% 3527
2021
Q3 		$283K Sell
500
-816
-62% -$401K ﹤0.01% 3100
2021
Q2 		$649K Buy
1,316
+859
+188% +$453K ﹤0.01% 2859
2021
Q1 		$283K Sell
457
-1,136
-71% -$594K ﹤0.01% 3073
2020
Q4 		$688K Buy
1,593
+42
+3% +$16.7K ﹤0.01% 2683
2020
Q3 		$523K Buy
1,551
+230
+17% +$64.8K ﹤0.01% 2801
2020
Q2 		$224K Buy
1,321
+636
+93% +$92.9K ﹤0.01% 3131
2020
Q1 		$99K Sell
685
-32
-4% -$6.34K ﹤0.01% 3231
2019
Q4 		$156K Buy
717
+30
+4% +$5.71K ﹤0.01% 3238
2019
Q3 		$129K Hold
687
– – ﹤0.01% 3230
2019
Q2 		$89K Hold
687
– – ﹤0.01% 3414
2019
Q1 		$115K Hold
687
– – ﹤0.01% 3283
2018
Q4 		$83K Hold
687
– – ﹤0.01% 3251
2018
Q3 		$109K Hold
687
– – ﹤0.01% 3235
2018
Q2 		$102K Hold
687
– – ﹤0.01% 3146
2018
Q1 		$193K Hold
687
– – ﹤0.01% 3184
2017
Q4 		$109K Hold
687
– – ﹤0.01% 3215
2017
Q3 		$103K Hold
687
– – ﹤0.01% 3077
2017
Q2 		$124K Hold
687
– – ﹤0.01% 3062
2017
Q1 		$185K Hold
687
– – ﹤0.01% 3010
2016
Q4 		$201K Hold
687
– – ﹤0.01% 3003
2016
Q3 		$268K Hold
687
– – ﹤0.01% 2991
2016
Q2 		$257K Hold
687
– – ﹤0.01% 2983
2016
Q1 		$338K Sell
687
-9
-1% -$3.8K ﹤0.01% 2957
2015
Q4 		$291K Sell
696
-143
-17% -$69.8K ﹤0.01% 2893
2015
Q3 		$413K Sell
839
-239
-22% -$155K ﹤0.01% 2680
2015
Q2 		$867K Buy
1,078
+562
+109% +$638K ﹤0.01% 2518
2015
Q1 		$444K Buy
+516
New +$296K ﹤0.01% 2642
2013
Q3 		– Sell
-76
Closed -$68K – 2884
2013
Q2 		$68K Buy
+76
New +$68.4K ﹤0.01% 2671

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Renaissance Technologies's KZIA Position: Q1 2022 in Review

Renaissance Technologies sold out of Kazia Therapeutics (KZIA) in Q1 2022, closing a stake of 449 shares — an estimated $189K sold.

Renaissance Technologies first reported a position in KZIA in Q2 2013 and held it in 29 quarters. The position peaked at $867K in Q2 2015. 11 funds tracked by Wall St. Rank hold KZIA as of Q1 2022.

  • Renaissance Technologies reported no remaining Kazia Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Renaissance Technologies sold 449 Kazia Therapeutics shares in Q1 2022, an estimated $189K.
  • Renaissance Technologies first reported a position in Kazia Therapeutics in Q2 2013 and held it in 29 quarters.
  • Renaissance Technologies's Kazia Therapeutics position peaked at $867K in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q1 2022.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.